Search Results

Search Results for "risperdal"


  • J&J Facing $8 Billion Jury Award in Risperdal Decision
    When Nicholas Murray was awarded $1.75 million in compensatory damages over claims that Johnson & Johnson’s anti-psychotic medication Risperdal caused him to develop breast tissue, he had every reason to believe that his ordeal had finally begun to come to an end. Having been diagnosed with au...
  • For Some Risperdal Users, Side Effect Reminder is as Close as Nearest Mirror
    Former users of Janssen Pharmaceuticals’ antipsychotic drug Risperdal continue to feel the impact of a long-undisclosed potential side effect of the medication. The drug is intended to treat schizophrenia and bipolar disorder, however, since its release, multiple misrepresentations about Risperdal...
  • Judge Shocks Both Sides with Move to Dismiss Risperdal Case
    Most of the time, a judge’s actions in a case are somewhat expected by at least one side. A plaintiff or defendant might argue for a particular action and the outcome is based on either the success or failure of that argument. However, every so often a judge does something that catches both sides ...
  • J&J to Pay $7.8 Million in Arkansas Risperdal Lawsuit
    Pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a seven-and-a-half-year-old Risperdal lawsuit, the Arkansas Democrat-Gazette reports. The state of Arkansas filed the lawsuit in 2007, alleging that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, unl...
  • Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits
    After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These dru...
  • J&J settles Risperdal lawsuit on first day of trial
    On the first day of trial, Johnson & Johnson settled a lawsuit centering on complaints that its antipsychotic drug Risperdal caused a male plaintiff to grow breasts, Bloomberg reports. The terms of the settlement are confidential. It was the first of about 130 lawsuits alleging that Risperdal ca...
  • Feds want to question new J&J CEO in Risperdal fraud case
    In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports. Government prosecutors charge that Johnson & Johnson paid kickbacks to Omnicare, ...
Page 1 of 4 1234